RBC Europe’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.37M Buy
3,916
+316
+9% +$129K 0.07% 94
2022
Q1
$1.97M Buy
3,600
+568
+19% +$299K 0.08% 86
2021
Q4
$2M Sell
3,032
-2,311
-43% -$1.45M 0.09% 82
2021
Q3
$3.32M Buy
5,343
+151
+3% +$101K 0.14% 85
2021
Q2
$3.28M Buy
5,192
+54
+1% +$29.8K 0.15% 89
2021
Q1
$2.51M Buy
5,138
+113
+2% +$56.6K 0.14% 98
2020
Q4
$2.51M Buy
5,025
+499
+11% +$223K 0.14% 92
2020
Q3
$1.78M Buy
4,526
+3,825
+546% +$1.41M 0.12% 97
2020
Q2
$231K Sell
701
-9,065
-93% -$2.62M 0.02% 219
2020
Q1
$2.37M Buy
9,766
+60
+0.6% +$15.7K 0.24% 66
2019
Q4
$2.53M Hold
9,706
0.22% 78
2019
Q3
$2.64M Sell
9,706
-575
-6% -$160K 0.26% 74
2019
Q2
$2.83M Hold
10,281
0.28% 68
2019
Q1
$2.3M Buy
10,281
+575
+6% +$119K 0.25% 75
2018
Q4
$1.81M Buy
9,706
+1,520
+19% +$312K 0.24% 77
2018
Q3
$2.04M Hold
8,186
0.23% 77
2018
Q2
$1.78M Sell
8,186
-990
-11% -$204K 0.21% 82
2018
Q1
$1.76M Sell
9,176
-65
-0.7% -$12K 0.21% 87
2017
Q4
$1.45M Buy
9,241
+4,866
+111% +$766K 0.18% 97
2017
Q3
$680K Buy
+4,375
New +$692K 0.09% 128

Other funds holding IDXX

RBC Europe's IDXX Position: Q2 2022 in Review

RBC Europe increased its Idexx Laboratories (IDXX) stake by 8.8% in Q2 2022, buying an estimated $129K and bringing the position to 3,916 shares worth $1.37M. The position accounts for 0.07% of the portfolio, ranked #94.

RBC Europe first reported a position in IDXX in Q3 2017 and has held it in 20 quarters since. The position peaked at $3.32M in Q3 2021. 957 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • RBC Europe held 3,916 shares of Idexx Laboratories worth $1.37M as of Q2 2022.
  • RBC Europe bought 316 Idexx Laboratories shares in Q2 2022, an estimated $129K.
  • Idexx Laboratories made up 0.07% of RBC Europe's portfolio in Q2 2022, its #94 holding.
  • RBC Europe first reported a position in Idexx Laboratories in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Idexx Laboratories position peaked at $3.32M in Q3 2021.
  • 957 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.